Q & A with Dr Ann Moen: How influenza preparedness helps fight other infectious diseases
Capacity building for influenza is critical because if you can prepare for and respond to flu outbreaks or respiratory events, you learn and practice for responses to other emerging diseases. Flu is not a sporadic outbreak like Ebola or Zika. It is always there, so there is always something to practice with and keep skills sharp. Because flu is a continual threat there is a lot of learning that goes on which also supports work on other emerging diseases. It ’s like the basic architecture for capacity building in all areas. For example, you can practice your communications for responding to outbreaks and better understand the behavioral aspects of vaccine hesitancy. You can build your laboratory capacity and surveillance and response capacity and use it for other things infectious threats such as MERS or SARS or other respiratory threats. Influenza can also help you learn how to implement a vaccine programme and introduce new drugs.
No abstract available
Thirty-four percent of US parents said their child was unlikely to get the flu vaccine this year, according to a report published Monday by C.S. Mott Children's Hospital.
GIDEON what’s new summary: November 16 to November 19, 2018 Infectious Diseases – Outbreaks (17 updates) 17 DiseasesMap Infectious Diseases – Diseases (82 updates) 30 Diseases52 Country notesMap Infectious Diseases – Drugs (1 updates) 1 Drug The post Update: November 19, 2018 appeared first on GIDEON - Global Infectious Diseases and Epidemiology Online Network.
This report highlights the potential of variant influenza outbreaks associated with agricultural fair settings in the United States, especially after direct or indirect swine contact.Morbidity &Mortality Weekly Report
(Michigan Medicine - University of Michigan) Nearly a third of parents say they are not planning to get their child the vaccine this year, according to the C.S. Mott Children's Hospital National Poll on Children's Health at the University of Michigan.
We present a rapid Raman assay for on-site analysis of stockpiled drugs in aqueous solution. This approach was tested on Tamiflu (oseltamivir phosphate). Tamiflu is a drug approved by the FDA for treatment of influenza and is the most common antiviral included in stockpiles for use in the event of a national emergency. Rapid assays were performed on three concentrations (30, 45, and 75 mg) of oseltamivir using three different portable &handheld Raman instruments. PLS regression models were developed to establish a calibration curve and applied to the Tamiflu samples. Raman assay values were compared against the stand...
CONCLUSION: To improve the early prescription of oseltamivir during the influenza season, two recommendations are essential: oseltamivir availability in the emergency department pharmacy, awareness of physicians of the need to prescribe to any patient hospitalized for a lower respiratory tract infection treatment with a neuraminidase inhibitor upon admission to the emergency department. PMID: 30446349 [PubMed - as supplied by publisher]
Discussion Guillian-Barré syndrome (GBS) is an acquired, acute, inflammatory, demyelinating polyneuropathy. It is the most common cause of acute and subacute flaccid paralysis in children. GBS causes about 0.4-1.3 cases per 100,000 persons/year in children. It can occur in any age group and the incidence increases among all age groups until a peak in the 50s. Both genders are affected and there may be a slight increase in males. GBS usually occurs 2-4 weeks after a prodromal gastroenteritis or respiratory illness. GBS causes autoantibody production against Schwann cells of the neuron and the axon itself. There is ...
ConclusionsImmunization coverage is high in the Kwabre East district but very few children received the second measles dose. None of the maternal and child factors assessed is associated with immunisation coverage. Further research is needed to identify the determinants of immunisation coverage and the reasons for the low uptake of second measles dose in the study area.
Across China, the virus that could spark the next pandemic is already circulating. It’s a bird flu called H7N9, and true to its name, it mostly infects poultry. Lately, however, it’s started jumping from chickens to humans more readily–bad news, because the virus is a killer. During a recent spike, 88% of people infected got pneumonia, three-quarters ended up in intensive care with severe respiratory problems, and 41% died. What H7N9 can’t do–yet–is spread easily from person to person, but experts know that could change. The longer the virus spends in humans, the better the chance that i...
More News: Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | Ebola | Ebola Vaccine | Flu Pandemic | Infectious Diseases | Influenza | Influenza Vaccine | International Medicine & Public Health | Laboratory Medicine | Learning | MERS | Outbreaks | Pandemics | Respiratory Medicine | SARS | Universities & Medical Training | Vaccines | Zika Virus